AtriCure Valuation
| ATRC Stock | USD 31.19 0.05 0.16% |
At this time, the firm appears to be undervalued. AtriCure shows a prevailing Real Value of $37.94 per share. The current price of the firm is $31.19. Our model approximates the value of AtriCure from analyzing the firm fundamentals such as Return On Equity of -0.024, profit margin of (0.02) %, and Current Valuation of 1.66 B as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting AtriCure's valuation include:
Price Book 3.6691 | Enterprise Value | Enterprise Value Ebitda (135.97) | Price Sales 2.9064 | Enterprise Value Revenue 3.3278 |
Undervalued
Today
Please note that AtriCure's price fluctuation is very steady at this time. Calculation of the real value of AtriCure is based on 3 months time horizon. Increasing AtriCure's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since AtriCure is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AtriCure Stock. However, AtriCure's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 31.19 | Real 37.94 | Target 49.38 | Hype 30.95 | Naive 30.58 |
The real value of AtriCure Stock, also known as its intrinsic value, is the underlying worth of AtriCure Company, which is reflected in its stock price. It is based on AtriCure's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of AtriCure's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of AtriCure helps investors to forecast how AtriCure stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AtriCure more accurately as focusing exclusively on AtriCure's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use AtriCure's intrinsic value based on its ongoing forecasts of AtriCure's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against AtriCure's closest peers. If more than one evaluation category is relevant for AtriCure we suggest using both methods to arrive at a better estimate.
AtriCure Cash |
|
AtriCure Total Value Analysis
AtriCure is presently projected to have valuation of 1.66 B with market capitalization of 1.55 B, debt of 88.02 M, and cash on hands of 118.45 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the AtriCure fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.66 B | 1.55 B | 88.02 M | 118.45 M |
AtriCure Investor Information
About 97.0% of the company shares are held by institutions such as insurance companies. The book value of AtriCure was presently reported as 9.88. The company recorded a loss per share of 0.24. AtriCure last dividend was issued on the 30th of September 2010. Based on the measurements of operating efficiency obtained from AtriCure's historical financial statements, AtriCure is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.AtriCure Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The latest return on assets of AtriCure indicates not a very effective usage of assets in February.AtriCure Profitability Analysis
Based on the measurements of profitability obtained from AtriCure's financial statements, AtriCure may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in March. Profitability indicators assess AtriCure's ability to earn profits and add value for shareholders.Net Loss | First Reported 2003-12-31 | Previous Quarter -267 K | Current Value 1.8 M | Quarterly Volatility 11.9 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.58 | 0.7441 |
|
|
For AtriCure profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AtriCure to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AtriCure utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AtriCure's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AtriCure over time as well as its relative position and ranking within its peers.
AtriCure Earnings per Share Projection vs Actual
By analyzing AtriCure's earnings estimates, investors can diagnose different trends across AtriCure's analyst sentiment over time as well as compare current EPS estimates against different timeframes. Please be aware that the consensus of earnings estimates for AtriCure is based on EPS before non-recurring items and includes expenses related to employee stock options.AtriCure Ownership Allocation
The majority of AtriCure outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AtriCure to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AtriCure. Please pay attention to any change in the institutional holdings of AtriCure as this could imply that something significant has changed or is about to change at the company.AtriCure Profitability Analysis
The company reported the previous year's revenue of 534.53 M. Net Loss for the year was (11.45 M) with profit before overhead, payroll, taxes, and interest of 400.78 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates AtriCure's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in AtriCure and how it compares across the competition.
About AtriCure Valuation
The stock valuation mechanism determines AtriCure's current worth on a weekly basis. Our valuation model uses a comparative analysis of AtriCure. We calculate exposure to AtriCure's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AtriCure's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 397.7 M | 417.6 M | |
| Pretax Profit Margin | (0.02) | (0.02) | |
| Operating Profit Margin | (0.01) | (0.01) | |
| Net Loss | (0.02) | (0.02) | |
| Gross Profit Margin | 0.74 | 0.58 |
AtriCure Current Valuation Indicators
Valuation refers to the process of determining the present value of AtriCure and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value AtriCure we look at many different elements of the entity such as AtriCure's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as AtriCure, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use AtriCure's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes AtriCure's worth.Complementary Tools for AtriCure Stock analysis
When running AtriCure's price analysis, check to measure AtriCure's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AtriCure is operating at the current time. Most of AtriCure's value examination focuses on studying past and present price action to predict the probability of AtriCure's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AtriCure's price. Additionally, you may evaluate how the addition of AtriCure to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |